LaserComb FDA Clearance Misconception

Posted by Jonny Harris

In this article: General Hair Loss


There seems to be a number of common misconceptions related to hair loss products, one of the most popular being the idea that the HairMax LaserComb has only been cleared by the FDA for safety, not effectiveness.

If you read the FDA clearance letter sent to HairMax (the manufacturers of the LaserComb) you will see that it clearly states ‘The LaserComb is indicated to promote hair growth in males with androgenetic alopecia who have Norwood Hamilton classification of IIa to V and Fitzpatrick skin types of I to IV.’ Here’s the FDA clearance letter.

HairMax carried out placebo-controlled clinical studies in order to prove the effectiveness of their device. Hopefully this information will clear this matter up. Here is a report related to a study carried out in 2014 - LaserComb Clinical Study.
Copy of New Street Ground Floor Reception 1 no pink nail polish

The Belgravia Centre

The Belgravia Centre is a world-renowned group of a hair loss clinic in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation from anywhere in the world for home-use treatment.

View our Hair Loss Success Stories, which includes the world's largest gallery of hair growth photos and demonstrates the level of success that so many of Belgravia's patients achieve.

belgravia logo

hairlossanswers

hairlossanswers

Do you have a question you would like the Belgravia Specialist to answer?

Posted by Jonny Harris

In this article: General Hair Loss